PL1
(Plasmid
#12394)
-
Depositing Lab
-
Publication
-
Sequence Information
Full plasmid sequence is not available for this item.
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 12394 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepet29 b(+)
- Backbone size w/o insert (bp) 5371
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Growth instructionsPlasmids are provided in DH5 alpha, but for protein expression, BL21(DE3)pLysS is recommended.
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert namePL1
-
Alt nameProtein L
-
Insert Size (bp)288
-
MutationRosettaDesign was used to design sequences. Alignment to wild-type can be seen in the article.
-
Tag
/ Fusion Protein
- 6xHis (C terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ sequencing primer T7 (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
A synthetic gene which placed the sequence under the control of the T7 promoter, a C-terminal 6X His tag, and codon usage optimized for Escherichia coli was obtained from BlueHeron Biotechnologies. The gene was then subcloned into the pet29 b(+) vector from Novagen.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
PL1 was a gift from David Baker (Addgene plasmid # 12394 ; http://n2t.net/addgene:12394 ; RRID:Addgene_12394) -
For your References section:
A large scale test of computational protein design: folding and stability of nine completely redesigned globular proteins. Dantas G, Kuhlman B, Callender D, Wong M, Baker D. J Mol Biol. 2003 Sep 12. 332(2):449-60. 10.1016/S0022-2836(03)00888-X PubMed 12948494